Vanguard Group’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $22.4M | Sell |
|
|||||
|
2025
Q2 | $10.2M | Sell |
|
|||||
|
2025
Q1 | $8.91M | Sell |
|
|||||
|
2024
Q4 | $15.9M | Buy |
|
|||||
|
2024
Q3 | $29.9M | Buy |
|
|||||
|
2024
Q2 | $53.1M | Buy |
|
|||||
|
2024
Q1 | $74.6M | Buy |
|
|||||
|
2023
Q4 | $37.8M | Sell |
|
|||||
|
2023
Q3 | $24.2M | Sell |
|
|||||
|
2023
Q2 | $35.7M | Buy |
|
|||||
|
2023
Q1 | $26.6M | Buy |
|
|||||
|
2022
Q4 | $28.3M | Sell |
|
|||||
|
2022
Q3 | $10.6M | Sell |
|
|||||
|
2022
Q2 | $9.23M | Buy |
|
|||||
|
2022
Q1 | $19.5M | Buy |
|
|||||
|
2021
Q4 | $28.2M | Buy |
|
|||||
|
2021
Q3 | $25.5M | Buy |
|
|||||
|
2021
Q2 | $11.3M | Buy |
|
|||||
|
2021
Q1 | $19M | Buy |
|
|||||
|
2020
Q4 | $414K | Buy |
|